- Conditions
- Diabetes, Pre-hypertension, Hypertension
- Interventions
- aliskiren 300 mg once daily, Placebo/sugar pill
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 19 Years to 80 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
Source: ClinicalTrials.gov public record
Updated May 10, 2017 · Synced May 21, 2026, 10:12 PM EDT